LIXT: Lixte Biotechnology Holdings, Inc. Stock

by  •  • Comments Off on LIXT: Lixte Biotechnology Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7.06
Enterprise Value ($M) 6.36
Book Value ($M) 3.99
Book Value / Share 1.78
Price / Book 1.77
NCAV ($M) 3.99
NCAV / Share 1.78
Price / NCAV 1.77

Profitability (mra)
Return on Invested Capital (ROIC) -1.27
Return on Assets (ROA) -1.17
Return on Equity (ROE) -1.25

Liquidity (mrq)
Quick Ratio 13.73
Current Ratio 13.73

Balance Sheet (mrq) ($M)
Current Assets 4.31
Assets 4.31
Liabilities 0.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.09
Net Income -5.09
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.29
Cash from Investing 0.00
Cash from Financing 3.14

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 161 18,411 0.87
2024-04-29 576 5,188 11.10
2024-04-26 500 1,216 41.12
2024-04-25 1,480 3,479 42.54

(click for more detail)

Similar Companies
LGVN – Longeveron Inc. LIFE – aTyr Pharma, Inc.
LIPO – Lipella Pharmaceuticals Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io